Compare NOCIL with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -5.23% of over the last 5 years
The company has declared Negative results for the last 5 consecutive quarters
With ROE of 3.6, it has a Very Expensive valuation with a 1.2 Price to Book Value
Falling Participation by Institutional Investors
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 2,162 Cr (Small Cap)
34.00
38
1.53%
-0.16
3.56%
1.24
Total Returns (Price + Dividend) 
Latest dividend: 2 per share ex-dividend date: Jul-30-2025
Risk Adjusted Returns v/s 
Returns Beta
News

NOCIL Ltd is Rated Strong Sell
NOCIL Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
NOCIL Ltd Technical Momentum Shifts Amid Bearish Sentiment
NOCIL Ltd, a key player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a bearish trend. Despite some mixed signals from monthly and weekly oscillators, the overall technical outlook has deteriorated, prompting a downgrade in its Mojo Grade to Strong Sell as of 20 Dec 2024. This article analyses the latest price movements, momentum indicators, and moving averages to provide a comprehensive view of the stock’s current technical stance.
Read full news article
NOCIL Ltd is Rated Strong Sell
NOCIL Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article Announcements 
NOCIL Limited - Analysts/Institutional Investor Meet/Con. Call Updates
05-Dec-2019 | Source : NSENOCIL Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
NOCIL Limited - Updates
06-Nov-2019 | Source : NSENOCIL Limited has informed the Exchange regarding 'Advertisement of Unaudited Financial Results '.
NOCIL Limited - Investor Presentation
05-Nov-2019 | Source : NSENOCIL Limited has informed the Exchange regarding Investor Presentation
Corporate Actions 
No Upcoming Board Meetings
NOCIL Ltd has declared 20% dividend, ex-date: 30 Jul 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
18.6633
Held by 9 Schemes (5.68%)
Held by 60 FIIs (4.47%)
Hrishikesh Arvind Mafatlal(as A Trustee Of Gurukripa Trust) (18.16%)
Icici Prudential Retirement Fund-pure Equity Plan (3.56%)
45.19%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -1.47% vs -4.66% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -23.68% vs -29.78% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -10.63% vs -1.70% in Sep 2024
Growth in half year ended Sep 2025 is -57.54% vs 12.58% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -7.63% vs -3.23% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -52.94% vs -10.24% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -3.60% vs -10.63% in Mar 2024
YoY Growth in year ended Mar 2025 is -22.66% vs -10.83% in Mar 2024






